These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26271128)

  • 21. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.
    Ducrocq G; Bhatt DL; Labreuche J; Corbalan R; Porath A; Gao R; Panchenko E; Liau CS; Ikeda Y; Goto S; Amarenco P; Steg PG
    Eur J Prev Cardiol; 2014 Dec; 21(12):1509-16. PubMed ID: 23965467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease.
    Kalra PR; Greenlaw N; Ferrari R; Ford I; Tardif JC; Tendera M; Reid CM; Danchin N; Stepinska J; Steg PG; Fox KM;
    Am J Med; 2017 Jun; 130(6):720-730. PubMed ID: 28109968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry.
    Barba R; Bisbe J; Pedrajas JN; Toril J; Monte R; Muñoz-Torrero JF; Monreal M;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):457-63. PubMed ID: 19369873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
    Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
    Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Andersen P; Kragholm K; Torp-Pedersen C; Jensen SE; Attar R
    Int J Cardiol; 2021 Nov; 343():131-137. PubMed ID: 34499974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
    Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
    Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
    PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
    Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
    Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
    Anand SS; Hiatt W; Dyal L; Bauersachs R; Berkowitz SD; Branch KRH; Debus S; Fox KAA; Liang Y; Muehlhofer E; Nehler M; Haskell LP; Patel M; Szarek M; Yusuf S; Eikelboom J; Bonaca MP
    Eur J Prev Cardiol; 2022 May; 29(5):e181-e189. PubMed ID: 34463737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease.
    Krishnamurthy V; Munir K; Rectenwald JE; Mansour A; Hans S; Eliason JL; Escobar GA; Gallagher KA; Grossman PM; Gurm HS; Share DA; Henke PK
    Vasc Med; 2014 Dec; 19(6):491-9. PubMed ID: 25292418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
    Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
    Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant use of proton pump inhibitors and clopidogrel in patients with coronary, cerebrovascular, or peripheral artery disease in the factores de Riesgo y ENfermedad Arterial (FRENA) registry.
    Muñoz-Torrero JF; Escudero D; Suárez C; Sanclemente C; Pascual MT; Zamorano J; Trujillo-Santos J; Monreal M;
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):13-9. PubMed ID: 21164357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Location of recurrent cardiovascular events and anticardiolipin antibodies.
    Galán-González J; Rico-Martín S; Calderón-García JF; Antón J; Ramírez-Moreno JM; Álvarez-Rodríguez LR; Sánchez Muñoz-Torrero JF;
    Eur J Clin Invest; 2021 Jul; 51(7):e13533. PubMed ID: 33666941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.